Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
通常取引
$274.74
−$2.59 · -0.93%
日中の時刻はETです。市場データは遅延する場合があります。
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
日中レンジ
現在 $274.74
52週レンジ
現在 $274.74
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
75
割安
センチメント
71
強気
リスク
31
中程度のリスク
モメンタム
47
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
日中レンジ
現在 $274.74
52週レンジ
現在 $274.74
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 251.16億 USD | 225.95億 USD | 204.98億 USD | 184.49億 USD | 171.08億 USD |
| 売上原価 | 90.51億 USD | 80.5億 USD | 80.04億 USD | 74.09億 USD | 63.99億 USD |
| 粗利益 | 160.65億 USD | 145.45億 USD | 124.94億 USD | 110.4億 USD | 107.09億 USD |
| 研究開発 | 15.82億 USD | 14.66億 USD | 12.93億 USD | 12.3億 USD | 11.33億 USD |
| 販売・一般管理 | 86.51億 USD | 75.03億 USD | 69.2億 USD | 60.76億 USD | 58.13億 USD |
| 営業費用 | 111.76億 USD | 108.56億 USD | 82.13億 USD | 73.06億 USD | 69.46億 USD |
| 受取利息 | 1.21億 USD | 1.39億 USD | 7500万 USD | 9400万 USD | 6800万 USD |
| 支払利息 | 6.07億 USD | 3.96億 USD | 3.56億 USD | 3.37億 USD | 3.37億 USD |
| 減価償却費と償却費 | 11.93億 USD | 10.5億 USD | 10.28億 USD | 9.98億 USD | 9.9億 USD |
| 営業利益 | 48.89億 USD | 36.89億 USD | 42.81億 USD | 37.34億 USD | 37.63億 USD |
| 純利益 | 32.46億 USD | 29.93億 USD | 31.65億 USD | 23.58億 USD | 19.94億 USD |
会社概要が更新されました 2026年10月12日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$368.11
上昇余地(33.98%)分割調整後の1株当たりの年間現金分配金。
$3.40
2025年(通年)+31.5% 以来 2021
2026年(一部):$2.64
$2.585
2,021
$2.835
2,022
$3.05
2,023
$3.24
2,024
$3.40
2,025
$2.64
2,026*
* 利用可能な配当履歴のうち、暦年の一部のみを含みます。
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当 | 2026年9月30日 | $0.88Quarterly | 2026年9月30日 | 2026年10月30日 |
配当 | 2026年6月30日 | $0.88Quarterly | 2026年6月30日 | 2026年7月31日 |
配当 | 2026年3月31日 | $0.88Quarterly | 2026年3月31日 | 2026年4月30日 |
配当 | 2025年12月31日 | $0.88Quarterly | 2025年12月31日 | 2026年1月30日 |
配当 | 2025年9月30日 | $0.84Quarterly | 2025年9月30日 | 2025年10月31日 |
配当 | 2025年6月30日 | $0.84Quarterly | 2025年6月30日 | 2025年7月31日 |
配当落ち 2026年9月30日
$0.88
Quarterly
2026年9月30日基準 · 支払日 2026年10月30日
配当落ち 2026年6月30日
$0.88
Quarterly
2026年6月30日基準 · 支払日 2026年7月31日
配当落ち 2026年3月31日
$0.88
Quarterly
2026年3月31日基準 · 支払日 2026年4月30日
配当落ち 2025年12月31日
$0.88
Quarterly
2025年12月31日基準 · 支払日 2026年1月30日
配当落ち 2025年9月30日
$0.84
Quarterly
2025年9月30日基準 · 支払日 2025年10月31日
配当落ち 2025年6月30日
$0.84
Quarterly
2025年6月30日基準 · 支払日 2025年7月31日
この株式へのエクスポージャーを報告している上場投資信託です。
State Street SPDR S&P 500 ETF1557.T1868.47億0.14%129.43兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI35.51億0.15%2.3兆 USD0.03%$382.21+0.07%
Vanguard S&P 500 ETFVOO29.68億0.17%1.8兆 USD0.03%$716.2+0.09%
iShares Core S&P 500 ETFIVV12.87億0.14%8964.4億 USD0.03%$782.67+0.09%
State Street SPDR S&P 500 ETFSPY11.8億0.14%8172億 USD0.09%$779.16+0.08%
State Street Health Care Select Sector SPDR ETFXLV6.88億1.58%435.37億 USD0.08%$171.05+0.14%
Vanguard Morningstar Growth ETFVUG6.47億0.17%3846億 USD0.03%$92.03+0.07%
Vanguard Dividend Appreciation ETFVIG6.32億0.48%1324億 USD0.04%$239.39+0.14%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Morningstar Growth ETFVUG
Vanguard Dividend Appreciation ETFVIGAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。